Title
Category
Credits
Event date
Cost
Let’s Take a BiTE Out of CRS and Neurotoxicity
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Lung Cancer Screening Essentials
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
Integrating Germline Pharmacogenomic Testing into Oncology Care
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.
Physical Therapy Approaches to Oncology Care: Beyond Lymphedema
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Tailored for medical providers, this session led by a physical therapist addresses challenges like speech and swallowing difficulties or pelvic floor issues in gynecological cancer. Explore the pivotal role of physical therapy in survivorship care plans and delve into current research supporting interventions for head and neck, gynecological, breast cancer, and other oncological conditions. Emphasizing interdisciplinary collaboration, we'll discuss the synergy between medical providers and physical therapists in delivering optimal cancer care. Additionally, learn the art of patient education in oncology rehabilitation, empowering medical providers to effectively communicate the role of physical therapy in cancer care.
Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
05/15/2024
$0.00
Melissa Holt, DNP, PMHNP-BC, and Lisa Stewart Kanser, PsyD will present on the topic of "Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment".
Assessing Anemia and Thrombocytopenia, and When to Be Concerned
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
06/19/2024
$0.00
Nancy Vogler, RN, MSN, AGPCNP, will present on "Assessing Anemia and Thrombocytopenia, and When to Be Concerned."
CPP Panel: Targeted Therapy Toxicities and Management
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
07/17/2024
$0.00
Kevin Chen, PharmD, MS; Aimee Faso, PharmD, BCOP, CPP; Bianka Patel, PharmD, BCOP, CPP, will discuss "CPP Panel: Targeted Therapy Toxicities and Management" in this months APP webinar series.

Pages